While PD-L1 signaling arises predominantly from tumor-associated macrophages, PD-L1 on DCs is an important regulator of tumor immunity, and PD-L1-PD-1 signaling restricts T-cell responses during cross-presentation (108). The gene discussed is CD274; the disease is neoplasm.